Search research articles
Contact Us
Filters
Showing results (31-40 of 47) with videos related to
Page
of 5
Sort By:
Oncogene
|
January 5, 2000
Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter
F Shirasaki, H A Makhluf, C LeRoy, et al.
The Journal of Biological Chemistry
|
March 30, 2001
Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway
J Czuwara-Ladykowska, F Shirasaki, P Jackers, et al.
The Journal of Experimental Medicine
|
May 1, 1992
Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts
A Yamakage, K Kikuchi, E A Smith, et al.
The Journal of Investigative Dermatology
|
August 1, 1992
Differential modulation of bFGF receptors by TGF-beta in adult skin, scleroderma skin, and newborn foreskin fibroblasts
K Kikuchi, A Yamakage, E A Smith, et al.
Arthritis Research
|
September 11, 2001
The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis
J Czuwara-Ladykowska, B Makiela, E A Smith, et al.
The Journal of Investigative Dermatology
|
January 14, 1999
Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3
S J Chen, W Yuan, Y Mori, et al.
Journal of Molecular Biology
|
April 5, 1987
Translational repression: biological activity of plasmid-encoded bacteriophage T4 RegA protein
E S Miller, J Karam, M Dawson, et al.
Biochemical and Biophysical Research Communications
|
August 31, 1992
Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF beta 1 stimulation
K Kikuchi, C W Hartl, E A Smith, et al.
Arthritis and Rheumatism
|
July 1, 1989
A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?
E C Leroy, E A Smith, M B Kahaleh, et al.
The British Journal of Dermatology
|
November 13, 2001
Differential regulation of transforming growth factor-beta receptors type I and II by platelet-derived growth factor in human dermal fibroblasts
J Czuwara-Ladykowska, E A Gore, D A Shegogue, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 47) with videos related to
Sort By:
Page
of 5
Oncogene
|
January 5, 2000
Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter
F Shirasaki, H A Makhluf, C LeRoy, et al.
The Journal of Biological Chemistry
|
March 30, 2001
Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway
J Czuwara-Ladykowska, F Shirasaki, P Jackers, et al.
The Journal of Experimental Medicine
|
May 1, 1992
Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts
A Yamakage, K Kikuchi, E A Smith, et al.
The Journal of Investigative Dermatology
|
August 1, 1992
Differential modulation of bFGF receptors by TGF-beta in adult skin, scleroderma skin, and newborn foreskin fibroblasts
K Kikuchi, A Yamakage, E A Smith, et al.
Arthritis Research
|
September 11, 2001
The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis
J Czuwara-Ladykowska, B Makiela, E A Smith, et al.
The Journal of Investigative Dermatology
|
January 14, 1999
Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3
S J Chen, W Yuan, Y Mori, et al.
Journal of Molecular Biology
|
April 5, 1987
Translational repression: biological activity of plasmid-encoded bacteriophage T4 RegA protein
E S Miller, J Karam, M Dawson, et al.
Biochemical and Biophysical Research Communications
|
August 31, 1992
Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF beta 1 stimulation
K Kikuchi, C W Hartl, E A Smith, et al.
Arthritis and Rheumatism
|
July 1, 1989
A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?
E C Leroy, E A Smith, M B Kahaleh, et al.
The British Journal of Dermatology
|
November 13, 2001
Differential regulation of transforming growth factor-beta receptors type I and II by platelet-derived growth factor in human dermal fibroblasts
J Czuwara-Ladykowska, E A Gore, D A Shegogue, et al.
Page
of 5